Ads
related to: keytruda- What Is KEYTRUDA?
Learn About What KEYTRUDA Is & How
It May Help Eligible Patients.
- Side Effects
Learn About Possible Side Effects
at the Official Patient Site.
- Treatment Options
Learn About Treatment
Options With KEYTRUDA.
- Get Financial Help
Find Assistance and Payment
Information for Eligible Patients.
- Clinical Trial Results
See Clinical Trial Results
at the Official Site.
- Taking KEYTRUDA?
Learn What to Expect When
Taking KEYTRUDA.
- What Is KEYTRUDA?
Search results
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
CNBC· 18 hours agoMerck said in February it was in the market for deals of up to $15 billion, and has already struck...
Merck Nears $1.3 Billion Cash Deal for Eye-Drug Company EyeBio, WSJ Reports
US News & World Report· 1 day agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and ...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Reuters via Yahoo Finance· 1 day agoMerck has said it's in the market for deals of up to around $15 billion as it plans ways to deal...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 16 hours agoHowever, Opdivo faces an upward climb as the urothelial cancer market is already dominated by Merck...
Merck to buy eye-focused drug developer EyeBio for as much as $3 bln
Reuters· 15 hours agoThe deal is the latest in a string of recent acquisitions by Merck to reduce its reliance on...
Merck To Pay as Much as $3 Billion for Eye Treatment Startup
Bloomberg· 18 hours agoHave a confidential tip for our reporters? Merck & Co. restocked its cabinet of eye treatments with...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Merck to pay as much as $3 billion for eye treatment startup
Crain's New York Business· 15 hours agoWhile it raised its profit and sales forecast for the year on Keytruda sales, Merck has been on the...
Merck stock climbs as breast cancer Phase 3 trial data meets endpoint By Investing.com
Investing.com· 2 days agoKeytruda is Merck’s immunotherapy medicine developed to treat different types of cancer. According...
Clean Energy Ventures closes second funding round - The Boston Globe
The Boston Globe· 8 hours agoChief executive Lauren Hobart has been expanding a new retail concept by renovating or relocating...
Ads
related to: keytruda